PDCD1 and neoplasm: PD‐L1 immunostaining showed PD‐L1‐positive areas were significantly reduced in the AI first group tumor, suggesting tumor shrinkage was attributed to the antitumoral effects of the anti‐PD‐1 antibody in this group (Figure 2E,F).